Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Biotricity Q4 2024 Adj EPS $(0.47) Misses $(0.36) Estimate, Sales $3.200M Inline

Author: Benzinga Newsdesk | June 27, 2024 08:26am
Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.36) by 30.56 percent. The company reported quarterly sales of $3.200 million which met the analyst consensus estimate. This is a 16.79 percent increase over sales of $2.740 million the same period last year.

Posted In: BTCY